- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Structure-based design of chimeric antigens for multivalent protein vaccines ; volume:9 ; number:1 ; day:13 ; month:3 ; year:2018 ; pages:1-10 ; date:12.2018
Nature Communications ; 9, Heft 1 (13.3.2018), 1-10, 12.2018
- Classification
-
Biowissenschaften, Biologie
- Creator
-
Hollingshead, S.
- Contributor
-
Jongerius, I.
Exley, R. M.
Johnson, S.
Lea, S. M.
Tang, C. M.
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-03146-7
- URN
-
urn:nbn:de:1111-201805132991
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hollingshead, S.
- Jongerius, I.
- Exley, R. M.
- Johnson, S.
- Lea, S. M.
- Tang, C. M.
- SpringerLink (Online service)
Other Objects (12)
Exploring the potential of novel multivalent DNA-based vaccines
Exploring the potential of novel multivalent DNA-based vaccines
Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers
Chimeric Antigen Receptor T-Cell Therapy
Expression and immunogenicity of DNA vaccines encoding chimeric antigens with a stress protein capturing, viral J-domain
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
P12-07. Novel HIV vaccines using chimeric influenza HA vectors
Exploring the potential of novel multivalent DNA-based vaccines
Exploring the potential of novel multivalent DNA-based vaccines
Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers
Chimeric Antigen Receptor T-Cell Therapy
Expression and immunogenicity of DNA vaccines encoding chimeric antigens with a stress protein capturing, viral J-domain
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
P12-07. Novel HIV vaccines using chimeric influenza HA vectors
Exploring the potential of novel multivalent DNA-based vaccines
Exploring the potential of novel multivalent DNA-based vaccines
Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers
Chimeric Antigen Receptor T-Cell Therapy
Expression and immunogenicity of DNA vaccines encoding chimeric antigens with a stress protein capturing, viral J-domain
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy